[en] Varicella zoster virus (VZV) is responsible for a primary infection (varicella.) and, upon reactivation, zoster, which in immunocompromised patients, may both lead to life-threatening disseminated disease. There is a great need for antiviral compounds that are effective inhibitors of VZV replication and for rapid and accurate methods for evaluating viral sensitivity to candidate anti-VZV drugs. With the monoclonal antibody (mAb) (VL8), which is directed against the gpI of VZV, and using the fluorescence-activated cell sorter (FACS) we could readily demonstrate expression of the VZV gpI antigen at 3-4 days after VZV infection. (E)-5-(2-Bromovinyl)-2'-deoxyuridine (BVDU), (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine (HPMPA) and (S)-1-(3-hydro-xy-2-phosphonylmethoxypropyl)cytosine (HPMC) were shown to be potent inhibitors of VZV replication by this assay. HPMPA and HPMPC were also active against thymidine kinase-deficient (TK-) VZV whereas BVDU was not. The flow cytometric method based on the use of mAb VL8 may be of considerable help for the early diagnosis of VZV infection and evaluation of viral sensitivity to antiviral drugs.
Disciplines :
Immunology & infectious disease
Author, co-author :
Snoeck, R.
Schols, D.
Sadzot-Delvaux, Catherine ; Université de Liège - ULiège > Département des sciences de la vie > Virologie et immunologie
Cloes, Jean-Michel
Andrei, G.
De Clercq, E.
Piette, Jacques ; Université de Liège - ULiège > Département des sciences de la vie > Virologie - Immunologie
Rentier, Bernard ; Université de Liège - ULiège > Département de Microbiologie > Virologie fondamentale et Immunologie
Language :
English
Title :
Flow cytometric method for the detection of gpI antigens of varicella zoster virus and evaluation of anti-VZV agents
Baba, Konno, Shigeta, De (1986) Inhibitory effects of selected antiviral compounds on newly isolated clinical varicella-zoster virus strains. The Tohoku Journal of Experimental Medicine 148:275-283.
Coligan, Kruisbeek, Margulies, Shevach, Strober Current Protocols in Immunology, Wiley, New York; 1991.
De Clercq, Holy, Rosenberg, Sakuma, Balzarini, Maudgal (1986) A novel selective broad-spectrum anti-DNA virus agent. Nature 323:464-467.
De, Sakuma, Baba, Pauwels, Balzarini, Rosenberg, Holy (1987) Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines. Antiviral Research 8:261-272.
Erlich, Mills, Chatis, Mertz, Busch, Follansbee, Grant, Crumpacker (1989) Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. New England Journal of Medicine 320:293-296.
Field (1989) Persistent herpes simplex virus infection and mechanisms of virus drug resistance. European Journal of Clinical Microbiology & Infectious Diseases 8:671-680.
Galfre, Howe, Milstein, Butcher, Howard (1977) Antibodies to major histocompatibility antigens produced by hybrid cell lines. Nature 266:550-552.
Grose (1980) The synthesis of glycoproteins in human melanoma cells infected with varicellazoster virus. Virology 101:1-9.
Jacobson, Berger, Fikrig, Becherer, Moohr, Stanat, Biron (1990) Acyclovir-resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS). Annals of Internal Medicine 112:187-191.
Köhler, Milstein (1976) Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion. European Journal of Immunology 6:511-519.
Linnemann, Biron, Hoppenjans, Solinger (1990) Emergence of acyclovir-resistant varicella zoster virus in an AIDS patient on prolonged acyclovir therapy. AIDS 4:577-579.
Littlefield (1964) Selection of hybrids from matings of fibroblasts in vitro and their presumed recombinants. Science 145:709.
Litwin, Sandor, Grose (1990) Cell surface expression of the varicella-zoster virus glycoproteins and Fc receptor. Virology 178:263-272.
Ljungman, Ellis, Hackman, Shepp, Meyers (1990) Acyclovirresistant herpes simplex virus causing pneumonia after marrow transplantation. Journal of Infectious Diseases 162:244-248.
Pahwa, Biron, Wilma, Swenson, Kaplan, Sadick, Rajendra (1988) Continuous varicella-zoster infection associated with acyclovir resistance in a child with AIDS. JAMA: The Journal of the American Medical Association 18:2879-2882.
Patti, Selvaggi, Kroboth (1990) Varicella hepatitis in the immunocompromised adult a case report and review of the literature. The American Journal of Medicine 88:77-80.
Pauwels, De, Desmyter, Balzarini, Goubau, Herdewijn, Vanderhaeghe, Vandeputte (1987) Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus. Journal of Virological Methods 16:171-185.
Safrin, Berger, Gilson, Wolfe, Wofsy, Mills, Biron (1991) Foscarnet therapy in five patients with AIDS and acyclovir-resistant varicella-zoster virus infection. Annals of Internal Medicine 115:19-21.
Schols, Snoeck, Neyts, De (1989) Detection of immediate early early and late antigens of human cytomegalovirus by flow cytometry. Journal of Virological Methods 26:247-254.
Shigeta, Yokota, Iwabuchi, Baba, Konno, Ogata, De Clercq (1983) Comparative efficacy of antiherpes drugs against virus strains of varicella-zoster virus. Journal of Infectious Diseases 147:576-584.
Snoeck, Sakuma, De Clercq, Rosenberg, Holy (1988) (S)-1-(3-Hydroxy-2-phosphonylmethoxypropyl)cytosine a potent and selective inhibitor of human cytomegalovirus replication. Antimicrobial Agents and Chemotherapy 32:1839-1844.
Snoeck, Schols, Andrei, Neyts, De (1991) Antiviral activity of anticytomegalovirus agents (HPMPC HPMPA) assessed by a flow cytometric method and DNA hybridization technique. Antiviral Research 16:1-9.
Taylor, Sviland, Pearson, Dobb, Reid, Kernahan, Craft, Hamilton, Proctor (1990) Virus infections in bone marrow transplant recipients a three year prospective study. Journal of Clinical Pathology 43:633-637.